An unusual, potent antibody to SARS-CoV-2 vari... - CLL Support

CLL Support

23,335 members40,040 posts

An unusual, potent antibody to SARS-CoV-2 variants is isolated from a recovered patient

bennevisplace profile image
10 Replies

Given time, ongoing mutation of the SARS-COV2 virus is likely to produce a super-lineage, at least as transmissible as the Delta variant and more resistant to current vaccines and monoclonal antibodies aimed at different targets in the receptor binding domain of the spike protein. A variety of candidate antibody therapeutics, insensitive to mutations found in major variants, may prove critical in the fight against COVID-19.

This paper cell.com/cell-reports/pdf/S... describes one such candidate antibody. It is highly technical. I don't know whether there is anything new in the technology, but the results should encourage others to prospect for therapeutic antibodies in the serum of recovered Covid patients.

"Here, we report a panel of SARS-CoV-2 antibodies... from an individual who recovered from COVID-19. Of these antibodies, 54042-4 shows potent neutralization against authentic SARS-CoV-2 viruses, including variants of concern (VOCs). A cryoelectron microscopy (cryo-EM) structure of 54042-4 in complex with the SARS-CoV-2 spike reveals an epitope composed of residues that are highly conserved in currently circulating SARS-CoV-2 lineages. Further, 54042-4 possesses uncommon genetic and structural characteristics that distinguish it from other potently neutralizing SARS-CoV-2 antibodies. Together, these findings provide motivation for the development of 54042-4 as a lead candidate to counteract current and future SARS-CoV-2 VOCs".

Written by
bennevisplace profile image
bennevisplace
To view profiles and participate in discussions please or .
Read more about...
10 Replies
Justasheet1 profile image
Justasheet1

If they can get out in front of this virus instead of chasing it we’ll be in much better shape for sure.

michaeledward profile image
michaeledward in reply toJustasheet1

". . . they . . . ?

Justasheet1 profile image
Justasheet1 in reply tomichaeledward

The scientists.

michaeledward profile image
michaeledward in reply toJustasheet1

OK. Just wondering though how much more "out in front" the scientists needed to be than developing, producing, and administering a vaccine within 12 months of the onset of the covid-19 pandemic. Myself, I blame certain very well know politicians who made the pandemic and mask wearing, for example, a political issue.

Justasheet1 profile image
Justasheet1 in reply tomichaeledward

I’m not assigning blame; it was just an observation of mine, that’s all.

gardening-girl profile image
gardening-girl

Thanks for this link! The 54042-4 monoclonal discussed in this paper was discovered by the same group at Vanderbilt University that isolated COV2-2196 and COV2-2130 which have since been engineered to be long-acting IgG molecules designated as AZD8895 and AZD1061, respectively, and since have been given new names: AZD8895/tixagevimab and AZD1061/cilgavimab.

These comprise the AZD7442 which has been discussed a number of times in this forum after an introduction by you about a year ago:

healthunlocked.com/cllsuppo...

Here is a link to a recent paper about the monoclonals that comprise AZD7442

pubmed.ncbi.nlm.nih.gov/345...

Now I wonder what 54042-4 will be called in the future. 😩

bennevisplace profile image
bennevisplace in reply togardening-girl

Thanks for your insights g-g,

This research team has certainly been productive! I see there's also a link to the full text, no paywall.

Given the current market for mAb treatments I wonder when 54042-4 will get developed, and as a cocktail ingredient or taken straight?

bennevisplace profile image
bennevisplace in reply togardening-girl

We're overdue a palyndromic name. I vote for Bamimomimab, the mother of all treatments.

Phil4-13 profile image
Phil4-13

bennevisplace, this sounds so "science fiction". It is ongoing for our science to at least keep up! Makes me think about the 1950's movie, "The Blob"!!! Creeepy!!!I'm keeping my prayers rolling to beat down this mutating virus. 🙂Sandra

bennevisplace profile image
bennevisplace in reply toPhil4-13

I don't know if you looked at the amazing graphics in that paper. Yes the microscopic world is so unfamiliar to most of us it's more like sci-fi than reality. Animations like thisyoutu.be/Rpj0emEGShQ could have been made by George Lucas.

Not what you're looking for?

You may also like...

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T

We evaluated 254 COVID-19 patients longitudinally from early infection and for eight months...
zaax profile image

Development of AstraZeneca's SARS-CoV2 spike monoclonal antibodies (AZD7442)

Thank you bennevisplace for posting about AstraZeneca's monoclonal antibody clinical trial for...

Compare your anti-SARS-CoV-2 Spike antibody results to those plotted in Figures 1 & 2.

Just for fun, I’ve extracted two figures from a paper reporting on levels of anti-SARS-CoV-2...

The failing effectiveness of COVID-19 monoclonal antibodies against BA.1, BA.4-5, BA.4.6, BA.2.75, BJ.1 and BQ.1.1

This post is in response to a couple of recent posts highlighting concerning changes in the...
AussieNeil profile image
Partner